MCGRATH YVONNE (VP, Research and Development) sold 7.93K shares of ITEOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $159.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/3/2021ACC: 0000899243-21-021777
Officer· VP, Research and Development
Since Jul 2020
-7.93K
Net shares
Net seller
$159.9K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
7.93K acquired · 15.85K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.60K
Price / share
$4.23
Trade value
$32.16K
% of position
New position
6/1/2021
0.00→7.60K
Common Stock
Direct
Shares
−7.60K
Price / share
$20.18
Trade value
$153.44K
% of position
New position
6/1/2021
7.60K→0.00
Common Stock
Direct
Shares
+323.00
Price / share
$4.23
Trade value
$1.37K
% of position
New position
6/2/2021
0.00→323.00
Common Stock
Direct
Shares
−323.00
Price / share
$20.00
Trade value
$6.46K
% of position
New position
6/2/2021
323.00→0.00
Total
Net shares
+0.00
Net value
-$126.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2021 | M · Option Exercise | +7.60K | $4.23 | $32.16K | New position | 0.00 | 7.60K |
| Common Stock Direct | 6/1/2021 | S · Sale | −7.60K | $20.18 | $153.44K | New position | 7.60K | 0.00 |
| Common Stock Direct | 6/2/2021 | M · Option Exercise | +323.00 | $4.23 | $1.37K | New position | 0.00 | 323.00 |
| Common Stock Direct | 6/2/2021 | S · Sale | −323.00 | $20.00 | $6.46K | New position | 323.00 | 0.00 |
| Total | +0.00 | -$126.37K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.60K shares
Shares
−7.60K
Strike price
4.23
Held after
103.37K
Exercisable
—
6/1/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
323.00 shares
Shares
−323.00
Strike price
4.23
Held after
103.05K
Exercisable
—
6/2/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.60K shares | 6/1/2021 | M · Option Exercise | −7.60K | 4.23 | — | 103.37K |
| Stock Option (Right to Buy) Direct | Common Stock323.00 shares | 6/2/2021 | M · Option Exercise | −323.00 | 4.23 | — | 103.05K |